RecruitingPhase 2NCT06895486

Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation

Studying Poliomyelitis

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
PATH
Principal Investigator
Xavier Saez Llorens, MD
Cevaxin
Intervention
Novel Oral Polio Vaccine Type 1 (nOPV1)(biological)
Enrollment
675 enrolled
Eligibility
All sexes
Timeline
20252026

Study locations (3)

Collaborators

Bill and Melinda Gates Foundation · PT Bio Farma · Centers for Disease Control and Prevention · Technical Resources International, Inc. (TRI) · Centro de Vacunación e Investigación (Cevaxin)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT06895486 on ClinicalTrials.gov

Other trials for Poliomyelitis

Additional recruiting or active studies for the same condition.

See all trials for Poliomyelitis

← Back to all trials